Dr. Greenstein answers the question: 'What Is After-Cataract, Can It Be Fixed?' Aug. 24, 2009— -- Question: What is after-cataract (posterior capsular opacification), and is there anything that ...

Please provide your email address to receive an email when new articles are posted on . VIENNA, Austria — A surgeon addressed the crucial issue of posterior capsular opacification after cataract ...

The incidence of PCO is known to range from as high as 50% to as low as <5% in eyes undergoing cataract surgery for uncomplicated senile cataracts. [13–16] Different methodologies have been used in ...

Please provide your email address to receive an email when new articles are posted on . Incidence of posterior capsular opacification may be higher in eyes after cataract surgery that underwent prior ...

To compare the development of posterior capsule opacification (PCO) between eyes with and without diabetes mellitus after single-piece hydrophobic acrylic intraocular lens implantation 4 years ...

In the present study, replication-defective Ad vectors expressing proapoptotic proteins were constructed. Ad vectors were chosen because they can transduce 100% of lens cells in vitro and in vivo, 9 ...

This page lists all known medications that could potentially lead to 'Posterior capsule opacification' as a side effect. It's important to note that mild side effects are quite common with medications ...

Dr. Mindy George-Weinstein, Professor of Biomedical Sciences at the Cooper Medical School of Rowan University, stated, "Myo/Nog cells have also been found in a variety of tumors, where we predict they ...

Cataract is a clouding of the lens within the eye and affects tens of millions of people. At present, there is no cure for cataract, and consequently the only available method to treat cataract is by ...

High-precision software for diagnosing eye sensitivity has been developed by researchers. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

HATFIELD, Pa., March 26, 2015 /PRNewswire/ -- Genisphere LLC, provider of the 3DNA® nanotechnology platform, reported today it has achieved specific immunodepletion of problematic Myo/Nog cells ...